Methyl iodide → HCID 46190280, compound
Reaction equation
[C:1]([C:3]1[CH:4]=[C:5]([N:25]2[C@H:29]([CH2:30][OH:31])[CH2:28][O:27][C:26]2=[O:32])[CH:6]=[CH:7][C:8]=1[C:9]([N:11]1[CH2:16][CH2:15][N:14]([C:17]2[C:22]([CH3:23])=[CH:21][C:20]([CH3:24])=[CH:19][N:18]=2)[CH2:13][CH2:12]1)=[O:10])#[N:2].[CH3:33]I>>[C:1]([C:3]1[CH:4]=[C:5]([N:25]2[C@H:29]([CH2:30][O:31][CH3:33])[CH2:28][O:27][C:26]2=[O:32])[CH:6]=[CH:7][C:8]=1[C:9]([N:11]1[CH2:12][CH2:13][N:14]([C:17]2[C:22]([CH3:23])=[CH:21][C:20]([CH3:24])=[CH:19][N:18]=2)[CH2:15][CH2:16]1)=[O:10])#[N:2]Participants
3
Procedure
By reaction and treatment in the same manner as in Preparation Example 93 and using (R)-3-{3-cyano-4-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-4-hydroxymethyloxazolidin-2-one (566 mg) described in Example 349 and methyl iodide (221 mg), the title compound (371 mg) was obtained.
Workup
- customBy reaction and treatment in the same manner
- customas in Preparation Example 93
Sources & evidence
- ORD record
- ord-d0bb2b95945f4a999053798cce9fdbbc
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08354401B2
Reaction notes
Loading…